Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Molecules (Basel, Switzerland)|July 27, 2022
Screening of Big Pharma's Library against Various in-house Biological TargetsDamijan Knez, Stanislav Gobec, Martina Hrast
ACS Omega|March 3, 2025
Facile Synthesis of Carbamoyl Fluorides via N-Carbamoylimidazole ActivationAnže Meden, Damijan Knez, Stanislav Gobec
Future Medicinal Chemistry|May 16, 2017
Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's diseaseDamijan Knez, Matej Sova, Urban Košak, et al.
Acta Pharmaceutica (Zagreb, Croatia)|July 3, 2025
α-Heteroarylthiomethyl ketones: Small molecule inhibitors of 3CLproDamijan Knez, Matic Proj, Krištof Bozovičar, et al.
Drug Discovery Today|March 18, 2022
Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compoundsMatic Proj, Damijan Knez, Izidor Sosič, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 7, 2022
Cell models for Alzheimer's and Parkinson's disease: At the interface of biology and drug discoverySandra Cetin, Damijan Knez, Stanislav Gobec, et al.
Molecules (Basel, Switzerland)|July 24, 2021
4-Phenethyl-1-Propargylpiperidine-Derived Dual Inhibitors of Butyrylcholinesterase and Monoamine Oxidase BTjaša Mazej, Damijan Knez, Anže Meden, et al.
Bioconjugate Chemistry|June 24, 2023
Tunable Heteroaromatic Nitriles for Selective Bioorthogonal Click Reaction with CysteineMatic Proj, Nika Strašek, Stane Pajk, et al.
Pharmacology & Therapeutics|November 9, 2024
Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's diseaseSvit Ferjančič Benetik, Damijan Knez, Aleš Obreza, et al.
Pageof 9